[practical information]

NLM AIDSLINE [Practical information]
August 30, 1991

Soins. 1991 Feb;(545):4. Unique Identifier : AIDSLINE MED/91220218 Acquired Immunodeficiency Syndrome/PREVENTION & CONTROL France Health Education/ORGANIZATION & ADMIN Human Public Health Administration/ORGANIZATION & ADMIN Substance Abuse, Intravenous/PREVENTION & CONTROL DIRECTORY

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 COLORADO: Boulder Groups Honor More Than 150 Local AIDS Victims PENNSYLVANIA: Area Residents Screened for Hepatitis C on Sunday COLORADO: Peer to Peer: Teens Work to Educate Peers on Pregnancy, STDs at CCHS OREGON: Portland Barefoot 3 x 3 Benefit Tournament to Draw Hundreds to Northeast Portland TEXAS: Temple - Wellness and Sexual Health Classes Helping Kids to Abstain CONNECTICUT: Yale Researchers Urge More Street Work When Studying People With Both HIV, Hepatitis C JAMAICA: AIDS Awareness Workshop Organised for High-School Students EUROPE: EU Issues Stringent Sharps Regulations CALIFORNIA: $50,000 Prisoner Prescription: Inmates Get Expensive Hepatitis C Treatment Tentative approval of lamivudine and tenofovir disoproxil fumarate Tablets, 300 mg/300 mg EDITORIAL: Focusing the Spotlight on Lack of Access to Health Information Prezista (darunavir) label change - drug interaction information UNITED STATES: Hepatitis Information Available in Ilocano, Pacific Islander Languages Kaletra (lopinavir/ritonavir) label update: drug interaction information The disabled often are denied information about sex and HIV Vertex Announces Update to U.S. Prescribing Information for INCIVEK® (telaprevir)FDA Approves Prescribing Information Update for EDURANT® (rilpivirine) to Include 96-Week Data in HIV-1-Infected Treatment-Naive Adult Patients Tuberculosis and HIV - background information Hepsera (adefovir dipivoxil) package insert updated to add new safety information Viramune XR (nevirapine) label includes new 100 mg tablet and added dosing information
Information in this article was accurate in August 30, 1991. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.